APOC3 and diabetes mellitus: Together, our observations raise an important question: Are the protective effects of APOC3 silencing on arterial cells in the setting of diabetes due to reduced direct effects of APOC3, caried into the lesion by lipoproteins, or to indirect effects mediated by reduced levels of circulating APOB-lipoprotein cholesterol and subsequently reduced levels of aortic free cholesterol?